Organization background
What Managed Health Care Associates (MHA) does
Managed Health Care Associates serves long-term-care, senior-living, specialty, infusion, combination, and other alternate-site organizations. Its public portfolio spans purchasing, reimbursement, analytics, pharmacy operating software, clinical services, and legislative resources.
MHA's current clinical-consulting page features RxPertise, but it identifies RxPertise as a SoftWriters solution. The ASCP listing is for MHA, not for RxPertise alone. Ask which MHA businesses and products are represented, and direct product-support, licensing, and roadmap questions to the party that owns each answer.
Broad alternate-site portfolio
MHA publishes services for LTC pharmacy, senior care, specialty, infusion, combination pharmacies, and other alternate-site providers.
Purchasing and reimbursement
Its public catalog includes pharmaceutical and business purchasing, an LTC reimbursement network, reconciliation, and rebate processing.
Clinical consulting software page
MHA presents RxPertise for consultant-pharmacist MRR while explicitly identifying it as a SoftWriters solution.
The booth can connect consultant work with the pharmacy and facility organizations that buy wider MHA services. For a software discussion, keep MHA, SoftWriters, and RxPertise roles explicit so support evidence and commercial terms are not attributed to the wrong organization.
Our read
Why they may be attending
The ASCP directory verifies Managed Health Care Associates in booth 517. It does not say the booth is solely about RxPertise. Our read is that the meeting creates a useful place to map MHA's wider LTC role and then identify exactly which organization owns current RxPertise sales, support, licensing, interfaces, and roadmap answers.
- Connect MHA's alternate-site services and software portfolio with long-term-care pharmacy decision-makers.
- Discuss clinical consulting needs that may involve RxPertise without presenting MHA and the SoftWriters product as the same entity.
- Route detailed purchasing, reimbursement, analytics, clinical, and product questions to the appropriate MHA or partner team.
Make the booth visit count
Questions worth taking with you
Which MHA services and software products are represented in this booth, and who owns each follow-up?
A clear responsibility map prevents a broad company relationship from obscuring product-specific answers.
For our RxPertise edition, who currently owns licensing, updates, technical support, and roadmap commitments?
MHA's public page identifies RxPertise as a SoftWriters solution, so roles should be explicit.
Are new RxPertise licenses available, and what support horizon and technical environment apply to an existing account?
A live support channel does not by itself answer commercial availability or product-lifecycle questions.
If a transition is being considered, what data, reports, history, exclusions, fees, validation, and rollback terms are documented?
One published customer migration does not establish parity or a reusable conversion scope for another organization.
Current official signal
Latest from Managed Health Care Associates (MHA)
Understanding Immunoglobulin Therapy: What Providers Need to Know
A company article discusses IVIG and SCIG market and operating considerations for infusion providers; its subject is broader than consultant-pharmacist MRR.
Official company-wide news and RSS feed covering MHA's broader alternate-site portfolio, not a dedicated RxPertise release history.